BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1404154)

  • 1. Macrophage infiltration in the skin of patients with systemic sclerosis.
    Ishikawa O; Ishikawa H
    J Rheumatol; 1992 Aug; 19(8):1202-6. PubMed ID: 1404154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages.
    Kräling BM; Maul GG; Jimenez SA
    Pathobiology; 1995; 63(1):48-56. PubMed ID: 7546275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma.
    Higashi-Kuwata N; Makino T; Inoue Y; Takeya M; Ihn H
    Exp Dermatol; 2009 Aug; 18(8):727-9. PubMed ID: 19320738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructure of cutaneous cellular infiltrates in scleroderma.
    Fleischmajer R; Perlish JS; West WP
    Arch Dermatol; 1977 Dec; 113(12):1661-6. PubMed ID: 202203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients.
    Giacomelli R; Matucci-Cerinic M; Cipriani P; Ghersetich I; Lattanzio R; Pavan A; Pignone A; Cagnoni ML; Lotti T; Tonietti G
    Arthritis Rheum; 1998 Feb; 41(2):327-34. PubMed ID: 9485091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the inflammatory infiltrate in lupus erythematosus lesions using monoclonal antibodies.
    Synkowski DR; Provost TT
    J Rheumatol; 1983 Dec; 10(6):920-4. PubMed ID: 6607342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical and ultrastructural demonstration of the lymphocyte-macrophage interaction in human aortic intima.
    Shimokama T; Haraoka S; Watanabe T
    Mod Pathol; 1991 Jan; 4(1):101-7. PubMed ID: 2020653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy.
    Chen MH; Chen MH; Liao SL; Chang TC; Chuang LM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):332-7. PubMed ID: 18284633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta.
    Del Galdo F; Maul GG; Jiménez SA; Artlett CM
    Arthritis Rheum; 2006 Aug; 54(8):2616-25. PubMed ID: 16868985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased transendothelial migration of scleroderma lymphocytes.
    Stummvoll GH; Aringer M; Grisar J; Steiner CW; Smolen JS; Knobler R; Graninger WB
    Ann Rheum Dis; 2004 May; 63(5):569-74. PubMed ID: 15082489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal T cells in the blood of patients with systemic sclerosis.
    Marie I; Cordel N; Lenormand B; Hellot MF; Levesque H; Courtois H; Joly P
    Arch Dermatol; 2005 Jan; 141(1):88-9. PubMed ID: 15655151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T lymphocyte subpopulations in progressive systemic sclerosis defined by monoclonal antibodies.
    Czirják L; Surányi P; Dankó K; Szegedi G
    Acta Med Hung; 1985; 42(3-4):129-32. PubMed ID: 3879347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies.
    Keystone EC; Lau C; Gladman DD; Wilkinson S; Lee P; Shore A
    Clin Exp Immunol; 1982 May; 48(2):443-8. PubMed ID: 6213329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo.
    Gross A; Tapia FJ; Mosca W; Perez RM; Briceño L; Henriquez JJ; Convit J
    Histol Histopathol; 1987 Jul; 2(3):277-83. PubMed ID: 2980730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connective tissue in skin biopsies from patients suffering systemic sclerosis.
    Quaglino D; Bergamini G; Boraldi F; Manzini E; Davidson JM; Pasquali Ronchetti I
    J Submicrosc Cytol Pathol; 1996 Apr; 28(2):287-96. PubMed ID: 8964053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early T cell activation in the skin from patients with systemic sclerosis.
    Kalogerou A; Gelou E; Mountantonakis S; Settas L; Zafiriou E; Sakkas L
    Ann Rheum Dis; 2005 Aug; 64(8):1233-5. PubMed ID: 16014686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.
    Mavalia C; Scaletti C; Romagnani P; Carossino AM; Pignone A; Emmi L; Pupilli C; Pizzolo G; Maggi E; Romagnani S
    Am J Pathol; 1997 Dec; 151(6):1751-8. PubMed ID: 9403725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.